Gerstein Fisher’s Regeneron Pharmaceuticals REGN Stock Holding History

Gerstein Fisher’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-605	Closed	-$218K	–	431
2016 Q1	$218K	Sell	605 -124	-17%	-$51.1K	0.03%	359
2015 Q4	$396K	Sell	729 -171	-19%	-$92.6K	0.06%	266
2015 Q3	$419K	Buy	900 +195	+28%	+$105K	0.06%	255
2015 Q2	$360K	Buy	705 +54	+8%	+$26.4K	0.06%	287
2015 Q1	$294K	Hold	651	–	–	0.05%	314
2014 Q4	$267K	Buy	651 +1	+0.2%	+$393	0.04%	314
2014 Q3	$234K	Buy	+650	New	+$218K	0.04%	340
2013 Q4	–	Sell	-10,865	Closed	-$3.4M	–	455
2013 Q3	$3.4M	Buy	10,865 +31	+0.3%	+$8.15K	0.74%	16
2013 Q2	$2.44M	Buy	+10,834	New	+$2.52M	0.59%	24

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Gerstein Fisher's REGN Position: Q2 2016 in Review

Gerstein Fisher sold out of Regeneron Pharmaceuticals (REGN) in Q2 2016, closing a stake of 605 shares — an estimated $218K sold.

Gerstein Fisher first reported a position in REGN in Q2 2013 and held it in 9 quarters. The position peaked at $3.4M in Q3 2013. 542 funds tracked by Wall St. Rank hold REGN as of Q2 2016.

Gerstein Fisher reported no remaining Regeneron Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
Gerstein Fisher sold 605 Regeneron Pharmaceuticals shares in Q2 2016, an estimated $218K.
Gerstein Fisher first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 9 quarters.
Gerstein Fisher's Regeneron Pharmaceuticals position peaked at $3.4M in Q3 2013.
542 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2016.

Based on Gerstein Fisher's 13F filing for Q2 2016, filed 8 Aug 2016.